Dr. Dimitrios Kontoyiannis, MD

• Infectious Disease Medicine

*Healthgrades does not verify qualifications for medical specialties. Please verify your provider's specialty and qualifications directly with your provider and applicable medical board.

• Ackerman College Of Chiropractic

  Medical School, 1987

• Loss of CclA, required for histone 3 lysine 4 methylation, decreases growth but increases secondary metabolite production inAspergillus fumigatus, 2013-02-19

• Reversible Ureteral Obstruction due to Polyomavirus Infection after Precutaneous Nephrostomy Catheter Placement, 2011-03-09

• First report of kerion (tinea capitis) caused by combinedTrichophyton mentagrophytesandMicrosporum canis, 2020-05-19

• Factors affecting patient outcome in primary cutaneous aspergillosis, 2016-07-01

• The gut mycobiome: The overlooked constituent of clinical outcomes and treatment complications in patients with cancer and other immunosuppressive conditions, 2020-04-02

• Performance of a Standardized Bronchoalveolar Lavage Protocol in a Comprehensive Cancer Center A Prospective 2-Year Study, 2011-01-18

• Necrotizing Mucormycosis of Wounds Following Combat Injuries, Natural Disasters, Burns, and Other Trauma, 2019-07-04

• Prevalent mutator genotype identified in fungal pathogenCandida glabratapromotes multi-drug resistance, 2016-03-29

• Author Correction: Iron restriction inside macrophages regulates pulmonary host defense againstRhizopusspecies, 2018-11-22

• Blockade of the PD-1/PD-L1 Immune Checkpoint Pathway Improves Infection Outcomes and Enhances Fungicidal Host Defense in a Murine Model of Invasive Pulmonary Mucormycosis, 2022-02-18

• Checkpoint inhibitors as immunotherapy for fungal infections: Promises, challenges, and unanswered questions, 2022-10-25

• 124. Establishment of a Post-Influenza Aspergillosis Model in Corticosteroid-Immunosuppressed Mice, 2021-12-04

• 1410. Isoniazid Therapy for Latent Tuberculosis Infection in Patients with Cancer Treated with Checkpoint Inhibitors Immunotherapy, 2021-12-04

• Impact of Hyperglycemia and Diabetes Mellitus on Breakthrough Mucormycosis Outcomes in Patients with Hematologic Malignancies-Complex and Intriguing Associations, 2022-12-28

• International multicenter study comparing COVID-19 in patients with cancer to patients without cancer: Impact of risk factors and treatment modalities on survivorship, 2023-01-30

• Fungal Infections in Transplant and Oncology Patients, 2010-04-26

• A Murine Model of Cutaneous Aspergillosis for Evaluation of Biomaterials-based Local Delivery Therapies, 2019-04-07

• Heterogenous lung inflammation CT patterns distinguish pneumonia and immune checkpoint inhibitor pneumonitis and complement blood biomarkers in acute myeloid leukemia: proof of concept, 2023-09-29

• Role and Interpretation of Antifungal Susceptibility Testing for the Management of Invasive Fungal Infections, 2020-12-30

• Therapy of Mucormycosis, 2018-07-31

• Invasive fungal infections in patients with cancer in the intensive care unit, 2012-02-14

• Breakthrough Mucormycosis Developing on Mucorales-Active Antifungals Portrays a Poor Prognosis in Patients with Hematologic Cancer, 2021-03-17

• Recent Advances in the Use ofDrosophila melanogasteras a Model to Study Immunopathogenesis of Medically Important Filamentous Fungi, 2012-02-19

• EGF-mediated suppression of cell extrusion during mucosal damage attenuates opportunistic fungal invasion, 2021-03-23

• Implementation of a Pan-Genomic Approach to Investigate Holobiont-Infecting Microbe Interaction: A Case Report of a Leukemic Patient with Invasive Mucormycosis, 2015-11-10

• Pneumonitis after immune checkpoint inhibitor therapies in patients with acute myeloid leukemia: a retrospective cohort study, 2022-04-22

• Symptomatic BK Virus Infection Is Associated with Kidney Function Decline and Poor Overall Survival in Allogeneic Hematopoietic Stem Cell Recipients, 2016-03-02

• Special Issue "Diagnosis and Treatment of Invasive Pulmonary Fungal Infections”, 2023-07-13

• Low-Volume Toolbox for the Discovery of Immunosuppressive Fungal Secondary Metabolites, 2013-04-11

• Azole-Resistance inAspergillus terreusand Related Species: An Emerging Problem or a Rare Phenomenon?, 2018-03-28

• Prevalence, clinical and economic burden of mucormycosis-related hospitalizations in the United States: a retrospective study, 2016-12-01

• Iron restriction inside macrophages regulates pulmonary host defense againstRhizopusspecies, 2018-08-20

• Candiduria in hematologic malignancy patients without a urinary catheter: nothing more than a frailty marker?, 2012-11-22

• When Uncontrolled Diabetes Mellitus and Severe COVID-19 Converge: The Perfect Storm for Mucormycosis, 2021-04-15

• PET-positive lymphadenopathy in CLL - Not always Richter transformation, 2017-02-07

• Environmental Candida auris and the Global Warming Emergence Hypothesis, 2021-03-16

• 710. Comparison of Initial CXR to CT in Patients (pts) with Hematologic Malignancy (HEM) and Documented Symptomatic Pulmonary Mucormycosis (PM), 2021-12-04

• Corrigendum: Azole-Resistance inAspergillus terreusand Related Species: An Emerging Problem or a Rare Phenomenon?, 2019-01-14

• Redundant synthesis of a conidial polyketide by two distinct secondary metabolite clusters inAspergillus fumigatus, 2015-09-03

• Identification and characterization of haemofungin, a novel antifungal compound that inhibits the final step of haem biosynthesis, 2016-01-07

• Guidelines and recommendations on yeast cell death nomenclature, 2018-01-01

• Mitochondrial Respiratory Pathways Inhibition inRhizopus oryzaePotentiates Activity of Posaconazole and Itraconazole via Apoptosis, 2013-05-17

• Impaired bactericidal but not fungicidal activity of polymorphonuclear neutrophils in patients with chronic lymphocytic leukemia, 2013-02-20

• Duration of Cytopenias with Concomitant Venetoclax and Azole Antifungals in Acute Myeloid Leukemia, 2021-04-01

• Development of new strategies for early diagnosis of mucormycosis from bench to bedside, 2015-06-05

• Mixed Mycobacterium Avium-Intracellulare and Serratia Marcescens Cellulitis of the Breast in an HIV-Negative Patient with Breast Cancer: A Case Report, 2016-06-09

• Are Unique Regional Factors the Missing Link in India's COVID-19-Associated Mucormycosis Crisis?, 2022-03-31

• Distinct Immunophenotypes of T Cells in Bronchoalveolar Lavage Fluid From Leukemia Patients With Immune Checkpoint Inhibitors-Related Pulmonary Complications, 2021-01-21

• On the Emergence of Candida auris : Climate Change, Azoles, Swamps, and Birds, 2019-07-23

• Methods of Controlling Invasive Fungal Infections Using CD8+T Cells, 2018-01-08

• Taking a Closer Look: Clinical and Histopathological Characteristics of Culture-Positive versus Culture-Negative Pulmonary Mucormycosis, 2022-04-08

• 22. International Multicenter Study Comparing Cancer to Non-Cancer Patients with COVID-19: Impact of Risk Factors and Treatment Modalities on Outcome, 2021-12-04

• Risk factors for Early Mortality in Hematological Malignancy Patients with Pulmonary Mucormycosis, 2013-06-12

• TH17 cells promote microbial killing and innate immune sensing of DNA via interleukin 26, 2015-07-13

• Observational Cohort Study of Oral Mycobiome and Interkingdom Interactions over the Course of Induction Therapy for Leukemia Robinson et al., 2020-04-15

• Patient-reported fatigue prior to treatment is prognostic of survival in patients with acute myeloid leukemia, 2018-07-27

• Clinical Uses of Inhaled Antifungals for Invasive Pulmonary Fungal Disease: Promises and Challenges, 2023-04-12

• Oral and Stool Microbiome Coalescence and Its Association With Antibiotic Exposure in Acute Leukemia Patients, 2022-03-31